CMC 360
Live / Registered — Registered (as of 10 Dec 2024)
What this means for you
Registered since 10 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97030574
- Registration number
- 7599867
- Mark type
- Design + words
- Filed
- 16 Sept 2021
- Published for opposition
- 10 Jan 2023
- Registered
- 10 Dec 2024
- Attorney of record
- Sara M. Bauer
Goods and services
- Class 035 — Advertising and business services: Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
- Class 042 — Scientific and technological services: Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials
- Class 045 — Legal and security services: Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences
Owner
- SYNER-G BIOPHARMA GROUP LLC, Framingham, MA, US
- SYNER-G BIOPHARMA GROUP LLC, Framingham, MA, US
- SYNER-G BIOPHARMA GROUP LLC, SOUTHBOROUGH, MA, US
- Syner-G Pharma Consulting, LLC, Southborough, MA, US
Prosecution history
- 10 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Sept 2024 — USE AMENDMENT FILED
- 07 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 06 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2024 — SOU EXTENSION 2 GRANTED
- 05 Mar 2024 — SOU EXTENSION 2 FILED
- 05 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED